Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2024
Cost-Utility Analysis of Antipsychotic Reduction and Discontinuation in Patients With Long-Term Schizophrenia and Psychosis in English Mental Health Trusts: The RADAR StudyGeorge Bray, Joanna Moncrieff, Stefan Priebe, et al.Journal of Medical Economics|August 2, 2026
Investing in enhanced HIV prevention among young men who have sex with men in Brazil: insights from fiscal health modelingGeorge Bray, Natalya Danchenko, Simon Brassel, et al.Metabolism: Clinical and Experimental|April 18, 2016
Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention ProgramRonald B Goldberg, Marinella Temprosa, Lisa Mele, et al.Obesity (Silver Spring, Md.)|April 12, 2007
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight lossNgozi Erondu, Thomas Wadden, Ira Gantz, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 22, 2017
Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD studyKathleen M Hayden, Laura D Baker, George Bray, et al.Contemporary Clinical Trials|December 15, 2022
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancersSophie Merrick, Matthew Nankivell, Matteo Quartagno, et al.BJOG : an International Journal of Obstetrics and Gynaecology|June 24, 2025
Economic Impact of Severe Early-Onset Foetal Growth Restriction: A Multicentre Prospective Cohort StudyGeorge Bray, Kasia Maksym, Maurvi Dilipkumar, et al.Cell Metabolism|October 3, 2006
Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adultsNgozi Erondu, Ira Gantz, Bret Musser, et al.The Lancet. Diabetes & Endocrinology|September 7, 2016
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial, Edward Gregg, John Jakicic, et al.Neurology|April 28, 2017
Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairmentMark A Espeland, José A Luchsinger, Laura D Baker, et al.Pageof 2